3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Prostatic Neoplasms
8
Leukemia
8
Burkitt Lymphoma
7
Recurrence
4
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Leukemia, Biphenotypic, Acute
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, B-Cell
2
Leukemia, Myeloid, Acute
2
Rhabdoid Tumor
1
Plasmablastic Lymphoma
1
Pituitary Neoplasms
1
Pituitary Diseases
1
Pancreatic Neoplasms
1
Neoplasms
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lung Neoplasms
1
Leukemia, T-Cell
1
Leukemia, Mast-Cell
1
Leukemia, Lymphoid
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Interventions
Temozolomide
115
Bevacizumab
72
Radiotherapy
52
Radiation
23
Erlotinib Hydrochloride
13
Lomustine
12
pembrolizumab
11
Magnetic Resonance Spectroscopy
11
Vorinostat
10
Nivolumab
10
Surgical Procedures, Operative
9
Irinotecan
9
Sorafenib
8
Radiotherapy, Intensity-Modulated
8
Radiotherapy, Conformal
7
Immunoglobulin G
7
Everolimus
7
Drug Therapy
7
Disulfides
7
Radiosurgery
6
Granulocyte-Macrophage Colony-Stimulating Factor
6
Carmustine
6
antineoplaston AS 2-1
5
antineoplaston A10
5
Sirolimus
5
Cilengitide
5
veliparib
4
veledimex
4
temsirolimus
4
selinexor
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Glioblastoma
×
Hydrocortisone
×
Clear all
No trials found.